(Q51564032)

English

Combination of low-dose folic acid and pyridoxine for treatment of hyperhomocysteinaemia in patients with premature arterial disease and their relatives.

scientific article published in March 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10208493

Combination of low-dose folic acid and pyridoxine for treatment of hyperhomocysteinaemia in patients with premature arterial disease and their relatives. (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10208493

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

van der Griend R

1

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10208493

Haas FJ

2

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10208493

Biesma DH

3

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10208493

Duran M

4

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10208493

Meuwissen OJ

5

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10208493

Banga JD

6

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10208493

publication date

1 March 1999

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10208493

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10208493

143

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10208493

1

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10208493

177-183

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10208493

Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900273-1

7 January 2021

Hyperhomocysteinemia: an independent risk factor for vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900273-1

7 January 2021

A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900273-1

7 January 2021

High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900273-1

7 January 2021

Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900273-1

7 January 2021

Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900273-1

7 January 2021

Serum total homocysteine and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900273-1

7 January 2021

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900273-1

7 January 2021

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900273-1

7 January 2021

Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900273-1

7 January 2021

Treatment of mild hyperhomocysteinemia in vascular disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900273-1

7 January 2021

Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900273-1

7 January 2021

Plasma homocysteine in acute myocardial infarction: homocysteine-lowering effect of folic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900273-1

7 January 2021

Sensory neuropathy with low-dose pyridoxine

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900273-1

7 January 2021

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900273-1

7 January 2021

Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900273-1

7 January 2021

Vitamin requirements for the treatment of hyperhomocysteinemia in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900273-1

7 January 2021

Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900273-1

7 January 2021

Gender differences and other determinants of the rise in plasma homocysteine after L-methionine loading

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900273-1

7 January 2021

Homocysteine increases as folate decreases in plasma of healthy men during short-term dietary folate and methyl group restriction

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900273-1

7 January 2021

Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900273-1

7 January 2021

Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900273-1

7 January 2021

The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900273-1

7 January 2021

Effect of various regimens of vitamin B6 and folic acid on mild hyperhomocysteinaemia in vascular patients

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900273-1

7 January 2021

Identifiers

10.1016/S0021-9150(98)00273-1

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10208493

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10208493

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51564032&oldid=1561555618"